CEACAM5 and female reproductive organ cancer: Emerging evidence indicates that carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) are established biochemical markers in plasma and tumors of patients with gynecological malignant tumors, according to emerging evidence [33].